FBIO
Fortress Biotech Inc
2.30$
-4.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | +1,809.6% | +1,038.3% | -85.7% | +36.3% | +24.5% | +50.9% | +10.1% | +11.6% | -31.8% | +9.7% | |
| – | – | – | – | -100.0% | – | – | – | -77.9% | +1,320.4% | -96.2% | +72.0% | +38.6% | +119.8% | -4.1% | -25.6% | -8.8% | +0.2% | |
| – | – | – | – | – | – | – | – | +494.6% | +414.2% | -21.3% | +25.7% | +18.8% | +18.4% | +22.5% | +37.0% | -40.3% | +15.1% | |
| – | -21.6% | +267.4% | +251.1% | -36.8% | +38.7% | -60.1% | +191.1% | +17.9% | +49.4% | +66.5% | -6.9% | -21.2% | +101.0% | +4.7% | -21.4% | -46.4% | -79.1% | |
| – | – | -65.5% | +539.4% | +50.6% | +16.5% | +3.1% | +107.3% | +44.2% | +134.7% | -26.9% | +4.2% | +10.0% | +42.0% | +30.9% | -12.3% | -12.0% | +9.9% | |
| – | -19.4% | +253.7% | +54.9% | +89.8% | +31.7% | -42.3% | +148.9% | +37.8% | +80.1% | +10.3% | -2.7% | -8.5% | +79.8% | +10.3% | -17.9% | -27.8% | -23.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +83.8% | -70.3% | -76.4% | +805.4% | +184.0% | -29.7% | +10.9% | +148.7% | +108.3% | +34.5% | +14.6% | +29.3% | -0.1% | -10.9% | -8.2% | -20.7% | -12.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -108.7% | – | +125.3% | +150.5% | -404.0% | – | – | -130.6% | – | – | +247.8% | -5.1% | +16.0% | -40.1% | -298.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.